Murat ÖZTÜRK, Isa AN, Ismail YİLDİZ, Derya UÇMAK, Egemen UCAN, Mustafa AKSOY

Neutrophil / Iymphocyte ratio, platelet / Iymphocyte ratio, mean platelet volume and C-reactive protein values in psoriatic arthritis patients

Aim: Studies have shown that neutrophil / lymphocyte ratio (NLR), platelet / lymphocyte ratio(PLR), mean platelet volume(MPV) andC-reactive protein(CRP) are higher in psoriatic arthritis patients than in the control group. In this study, NLR, PLR and MPV values ofpatients with psoriatic arthritis were calculated and if these parameters were related to CRP levels.Material and Methods: 74 psoriatic arthritis patients and 77 healthy controls without any systemic, infectious and autoimmunediseases were included in the study. Patients were divided into two groups according to their CRP values: normal (0-0.5 mg / dl) andhigh (> 0.5 mg / dl)Results: NLR, MPV and CRP values in the patient group were significantly higher than the control group. PLR value in the patientgroup was higher than the control group but the difference between them was not statistically significant. There was a statisticallysignificant relationship between CRP and NLR and MPV values in psoriatic arthritis patients.Conclusion: Since NLR and MPV were significantly higher in psoriatic arthritis patients than in the control group and there was astatistically significant relationship with CRP elevation, it was thought that they were appropriate parameters to show inflammationin patients with psoriatic arthritis.

PDF

___

1. An İ. tatuaj komplikasyonu olarak tip 2 köbner fenomeni gelişen psoriasisli bir olgu. Dermatoz 2018;9:1809204.
2. Kılıc S, Resorlu H, Işik S, et al. Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis. Postepy Dermatol Alergol 2017;34:126-30.
3. Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Derma-tol 2016;43:305-10.
4. Asahina A, Kubo N, Umezawa Y, et al. Neutrophil– lymphocyte ratio, platelet–lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. J Dermatol 2017;44:1112-21.
5. Kerschbaumer A, Fenzl KH, Erlacher L, et al. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr 2016;128:791-5.
6. Kasapkara HA, Aslan AN, Ayhan H, et al. Higer neutrophil to lymphocyte ratio is related to a lower ejectionfraction in bicuspid aortic valve patients. Turk J Med Sci. 2016;46:1144- 50.
7. Özgehan G, Kahramanca Ş, Kaya İO, et al. Neutrophillymphocyte ratio as a predictive factor for tumor staging in colorectal cancer. Turk J Med Sci 2014;44:365-8.
8. Kılıç S, Işık S, Hiz MM, et al. The ischemia modified albumin and mean platelet volume levels in patients with Behçet’s disease. Postepy Dermatol Alergol 2016;33:345-8.
9. Sahpaz P, Ulutas KT. İnsülin veya oral anti diyabetik ilaç alan tip 2 diyabetli hastalarda ortalama trombosit hacminin değerlendirilmesi. Dicle Tıp Dergisi 2015;42:399-403.
10. Pamuk GE, Nuri Pamuk O, Orum H, et al. Elevated plateletmonocyte complexes in patients with psoriatic arthritis. Platelets 2009;20:493-7.
11. Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio beter predicts inflammation than neutrophil-tolymphocyte ratio in end-stage renal disease patients. Hemodial Int 2013;17:391-6.
12. Kim DS, Lee J, Kim SH, et al. Mean platelet volume is elevated in patients with psoriasis vulgar-is. Yonsei Med J 2015;56:712-8.
13. Canpolat F, Akpinar H, Eskioğlu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 2010;29:325-8.
14. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
15. Balta S, Cakar M, Demirkol S, et al. Higher neutrophil to lymphocyte ratio in patients with meta-bolic syndrome. Clin Appl Thromb Hemost 2013;19:579.
16. An I, Ucmak D, Ozturk M. Evaluation of neutrophil-tolymphocyte ratio, platelet-tolymphocyte ratio and mean platelet volume in patients with lichen planus. Ann Med Res 2019;26:161-4.
17. An I, Ucmak D. Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in patients with psoriasis vulgaris. Dicle Med J 2018;45:327-34.
18. Cemil BC, Ataş H. Psoriasis Hastalarında Biyolojik Tedavinin Sistemik İnflamatuvar Belirteçler ve Plateletcrit Üzerine Etkisi. Dicle Tıp Dergisi.2016;43:477-83.
19. Unal M, Küçük A, Ünal GÜ, et al. Psoriasiste ortalama trombosit hacmi, nötrofil/lenfosit oranı ve trombosit/ lenfosit oranı. Turkderm 2015;49:112-6.
20. Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2015;74:326-32.
21. Prey S, Paul C, Bronsard V, et al. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 2010;24:31-5.
22. Uslu AU, Küçük A, Sahin A, et al. Two new inflammatory markers associated with disease activ-ity score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 2015;18:731-5.
23. Katoh N. Platelets as versatile regulators of cutaneous inflammation. J Dermatol Sci 2009;53:89-95.
24. Schottelius AJ, Moldawer LL, Dinarello CA, et al. Biology of tumor necrosis factor-alpha impli-cation for psoriasis. Exp Dermatol 2004;13:193-222.
25. Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vul-garis according to severity and therapy. JEADV 2010;24:789-96.
26. Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literature JEADV 2014;28:700-11.
27. Asahina A, Umezawa Y, Yanaba K, et al. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: long-term differential effects of biologics. J Dermatol 2016;43:779-84. Ann Med Res 2019;26(5):894-8 898